CC BY 4.0 · World J Nucl Med 2023; 22(04): 284-288
DOI: 10.1055/s-0043-1768448
Case Report

Familial MEN1 Syndrome Diagnosed on Functional Imaging: A Case Report with Clinical and Genetic Correlation

1   Radiation Medicine Centre, Tata Memorial Hospital Annexe, BARC, Mumbai, Maharashtra, India
2   Radiation Medicine Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Radiation Medicine Centre, Tata Memorial Hospital Annexe, BARC, Mumbai, Maharashtra, India
› Author Affiliations

Funding None.

Abstract

Multiple endocrine neoplasia, type 1 (MEN1) syndrome is an autosomal dominant disease characterized by tumors involving parathyroid, pituitary, and pancreas. The diagnosis is mostly clinical and by the presence of MEN1 gene mutation. We present a case with initial presentation of neuroendocrine tumor of pancreas whose ancillary findings on 68Ga-DOTATATE positron emission tomography-computed tomography helped in raising suspicion of MEN1, which was confirmed on genetic testing and family history. We emphasize the importance of using gestalt approach in such cases to avoid misdiagnosis or delay. Additionally, we describe the clinical profile of affected family members with their MEN1 gene mutation status, highlighting the gestalt approach again to uncover the unknowns.

Informed Consent

Relatives of the patient have been informed that we are obligated to protect his privacy and not to disclose his personal information. They have given permission to publish or present this case report voluntarily.


Authors' Contributions

AK was involved in conceptualization, methodology, design, analysis, interpretation, data curation, writing (review and editing), and visualization. AK agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. AC helped in data acquisition, data curation, and drafting of the article.


Ethical Approval

We abided by the Declaration of Helsinki diligently.




Publication History

Article published online:
04 December 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Thakker RV, Newey PJ, Walls GV. et al; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 2012; 97 (09) 2990-3011
  • 2 Kamilaris CDC, Stratakis CA. Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis. Front Endocrinol (Lausanne) 2019; 10: 339
  • 3 Yoshimoto K. Multiple endocrine neoplasia type 1: from bedside to benchside. J Med Invest 2000; 47 (3-4): 108-117
  • 4 Tepede AA, Welch J, Lee M. et al. 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma. Endocrinol Diabetes Metab Case Rep 2020; 2020: 19-0156 ; Epub ahead of print
  • 5 Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV. Diagnostic challenges due to phenocopies: lessons from multiple endocrine neoplasia type1 (MEN1). Hum Mutat 2010; 31 (01) E1089-E1101
  • 6 Falchetti A. Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.. F1000Res. 2017; 6: F1000 . doi: Faculty Rev-73. PMID: 28184288; PMCID: PMC5288685.
  • 7 Kövesdi A, Tóth M, Butz H. et al. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 2019; 65 (02) 451-459
  • 8 Mele C, Mencarelli M, Caputo M. et al. Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations. Front Endocrinol (Lausanne) 2020; 11: 591501
  • 9 Morgat C, Vélayoudom-Céphise FL, Schwartz P. et al. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1. Eur J Nucl Med Mol Imaging 2016; 43 (07) 1258-1266
  • 10 Sadowski SM, Millo C, Cottle-Delisle C. et al. Results of (68)Gallium-DOTATATE PET/CT scanning in patients with multiple endocrine neoplasia type 1. J Am Coll Surg 2015; 221 (02) 509-517
  • 11 Lastoria S, Marciello F, Faggiano A. et al. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1). Endocrine 2016; 52 (03) 488-494